about
Breast cancer vaccines: a clinical reality or fairy tale?Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors.Adoptive T-cell therapy for the treatment of solid tumours.Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo.A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN).Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patientsTranslating the concept of suppressor/regulatory T cells to clinical applications.Cysteine cathepsins: regulators of antitumour immune response.Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.Passive immunotherapeutic strategies for the treatment of malignant gliomas.Use of ultraviolet-light irradiated multiple myeloma cells as immunogens to generate tumor-specific cytolytic T lymphocytes.IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansion.A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2.An array of immunotherapeutic strategies for B-cell lymphomas
P2860
Q30351838-79B9C5D3-A6FE-4AA2-9718-C604204A274CQ33653487-E09017D0-7AD5-40EC-9EED-F6F751EF202DQ34068188-8D292D83-B5BA-47CE-9555-727F6FB0BE61Q34482064-422D6494-1A70-400D-81B1-A5DAAD5057A9Q34727843-9D04A82C-5425-4745-9441-2476C6FCA3D7Q35238022-319C4B8E-D5B1-4B60-8F7B-B49CDD6E6DCEQ36011425-5FB8722D-7E01-4E33-8F78-5CBCE2FCE3DDQ36466223-C1E6D2D6-A4CA-4AEA-98E1-2EAA44168D75Q36708304-A02B4331-E2A0-4796-823A-D325043E37EDQ37257207-93619452-B6B1-41A9-983C-32DC035DF4C8Q37714783-6474BDA4-31A2-4903-AFB1-C11AA2CA6708Q38445333-D2A6FD33-9D11-46BB-9CCE-B80E19E5EAD2Q40596665-36496125-2AF9-4B40-96E0-1B28B451E372Q40602227-33CE1378-8FF0-4B24-BD46-2824048DEC73Q57556559-957013F3-DEA2-41B3-A091-ABDC729FC874
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Therapy with cultured T cells: principles revisited.
@en
type
label
Therapy with cultured T cells: principles revisited.
@en
prefLabel
Therapy with cultured T cells: principles revisited.
@en
P2860
P1476
Therapy with cultured T cells: principles revisited.
@en
P2093
P2860
P304
P356
10.1111/J.1600-065X.1997.TB00982.X
P577
1997-06-01T00:00:00Z